Tag: MAJESTIC
Eluvia paclitaxel-eluting vascular stent system demonstrates promising three-year freedom from revascularisation
The three-year results from the MAJESTIC trial for Boston Scientific’s Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological Society of Europe...
Stefan Müller-Hülsbeck: The current drug-eluting stent landscape
In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses...
